Literature DB >> 19636954

Backbone and sidechain 1H, 13C and 15N resonance assignments of the human brain-type fatty acid binding protein (FABP7) in its apo form and the holo forms binding to DHA, oleic acid, linoleic acid and elaidic acid.

Jesper S Oeemig1, Mathilde L Jørgensen, Mikka S Hansen, Evamaria I Petersen, Laurent Duroux, Reinhard Wimmer.   

Abstract

In this manuscript, we present the backbone and side chain assignments of human brain-type fatty acid binding protein, also known as FABP7, in its apo form and in four different holo forms, bound to DHA, oleic acid, linoleic acid and elaidic acid.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19636954     DOI: 10.1007/s12104-009-9148-6

Source DB:  PubMed          Journal:  Biomol NMR Assign        ISSN: 1874-270X            Impact factor:   0.746


  4 in total

1.  Hydrogen-bonded His93 as a sensitive probe for identifying inhibitors of the endocannabinoid transport protein FABP7.

Authors:  Sergiy Tyukhtenko; Karrie Chan; Rubin Jiang; Han Zhou; Richard W Mercier; De-Ping Yang; Alexandros Makriyannis; Jason J Guo
Journal:  Chem Biol Drug Des       Date:  2014-10-16       Impact factor: 2.817

2.  BLBP Is Both a Marker for Poor Prognosis and a Potential Therapeutic Target in Paediatric Ependymoma.

Authors:  Durgagauri H Sabnis; Jo-Fen Liu; Lucy Simmonds; Sophie Blackburn; Richard G Grundy; Ian D Kerr; Beth Coyle
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

3.  Probing the interaction of brain fatty acid binding protein (B-FABP) with model membranes.

Authors:  Fábio Dyszy; Andressa P A Pinto; Ana P U Araújo; Antonio J Costa-Filho
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

4.  A radial glia gene marker, fatty acid binding protein 7 (FABP7), is involved in proliferation and invasion of glioblastoma cells.

Authors:  Antonella De Rosa; Serena Pellegatta; Marco Rossi; Patrizia Tunici; Letizia Magnoni; Maria Carmela Speranza; Federico Malusa; Vincenzo Miragliotta; Elisa Mori; Gaetano Finocchiaro; Annette Bakker
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.